Donald S. Brooks

88 year

Health Technology

Consumer Services

Profile

Donald S.
Brooks served as an Independent Director at CASI Pharmaceuticals, Inc. from 2011 to 2012.
He also held positions as an Independent Non-Executive Director at BioDiem Ltd., Director at Xenon Pharmaceuticals, Inc., and Senior Counsel-Licensing at Merck & Co., Inc. Brooks is a graduate of Columbia Law School.

Former positions of Donald S. Brooks

Companies	Position	End
CASI Pharmaceuticals, Inc. /Old/ CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.	Director/Board Member	2012-01-26
MERCK & CO., INC.	General Counsel	1992-12-31
BioDiem Ltd. BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia.	Director/Board Member	-
XENON PHARMACEUTICALS INC.	Director/Board Member	-

See the detail of Donald S. Brooks's experience

Training of Donald S. Brooks

Columbia Law School

Graduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Donald S. Brooks's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	2
MERCK & CO., INC.	Health Technology
XENON PHARMACEUTICALS INC.	Health Technology

Private companies	2
CASI Pharmaceuticals, Inc. /Old/ CASI Pharmaceuticals, Inc. /Old/ Pharmaceuticals: MajorHealth Technology CASI Pharmaceuticals, Inc. is a biopharmaceutical company, which is focused on the acquisition, development and commercialization of therapeutics addressing cancer and other unmet medical needs. The company develops and commercializes the oncology drugs and drug candidates in China, Taiwan, Hong Kong, and Macau. Its products include Zevalin, Evomela, and Marqibo. The company was founded in 1991 and is headquartered in Rockville, MD.	Health Technology
BioDiem Ltd. BioDiem Ltd. Pharmaceuticals: MajorHealth Technology BioDiem Ltd. operates as a biotechnology company. It focuses on development and commercialization of pharmaceutical and biomedical research, vaccines and infectious disease therapies and securing licences of biopharmaceutical products currently under development. The firm's development programs include: expansion of the live attenuated influenza virus-based flu vaccine licensing business, development of the antimicrobial BDM-I for the treatment of serious infectious diseases, scrambled antigen vaccine and viral vector systems. The company was founded on May 18, 2001 and is headquartered in South Melbourne, Australia.	Health Technology